A DNA methylation map of human cancer at single base-pair resolution

Although single base-pair resolution DNA methylation landscapes for embryonic and different somatic cell types provided important insights into epigenetic dynamics and cell-type specificity, such comprehensive profiling is incomplete across human cancer types. This prompted us to perform genome-wide DNA methylation profiling of 22 samples derived from normal tissues and associated neoplasms, including primary tumors and cancer cell lines. Unlike their invariant normal counterparts, cancer samples exhibited highly variable CpG methylation levels in a large proportion of the genome, involving progressive changes during tumor evolution. The whole-genome sequencing results from selected samples were replicated in a large cohort of 1112 primary tumors of various cancer types using genome-scale DNA methylation analysis. Specifically, we determined DNA hypermethylation of promoters and enhancers regulating tumor-suppressor genes, with potential cancer-driving effects. DNA hypermethylation events showed evidence of positive selection, mutual exclusivity and tissue specificity, suggesting their active participation in neoplastic transformation. Our data highlight the extensive changes in DNA methylation that occur in cancer onset, progression and dissemination.

[1]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[2]  Michael J. Ziller,et al.  Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. , 2014, Cancer cell.

[3]  David T. W. Jones,et al.  Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.

[4]  Roland Eils,et al.  DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control , 2015, Nature Genetics.

[5]  Vijay K. Tiwari,et al.  DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.

[6]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[7]  Junjun Zhang,et al.  BioMart Central Portal—unified access to biological data , 2009, Nucleic Acids Res..

[8]  Andrew P. Feinberg,et al.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host , 2013, Nature Reviews Cancer.

[9]  Manolis Kellis,et al.  ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.

[10]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[11]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[12]  Alfonso Valencia,et al.  Distinct DNA methylomes of newborns and centenarians , 2012, Proceedings of the National Academy of Sciences.

[13]  P. Laird,et al.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.

[14]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[15]  B. Langmead,et al.  BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions , 2012, Genome Biology.

[16]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[17]  W. Richard McCombie,et al.  Sperm Methylation Profiles Reveal Features of Epigenetic Inheritance and Evolution in Primates , 2011, Cell.

[18]  Michael B. Stadler,et al.  Identification of active regulatory regions from DNA methylation data , 2013, Nucleic acids research.

[19]  E. Ingley.  Functions of the Lyn tyrosine kinase in health and disease , 2012, Cell Communication and Signaling.

[20]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[21]  Julie V. Harness,et al.  Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment , 2014, Genome research.

[22]  Ji Luo,et al.  The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. , 2010, Cancer research.

[23]  S. Rafii,et al.  Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. , 2011, Molecular cell.

[24]  M. Esteller,et al.  EZH2: an epigenetic gatekeeper promoting lymphomagenesis. , 2013, Cancer cell.

[25]  A. Feinberg.  Phenotypic plasticity and the epigenetics of human disease , 2007, Nature.

[26]  A. Feinberg,et al.  Regulated Noise in the Epigenetic Landscape of Development and Disease , 2012, Cell.

[27]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[28]  Wendy P Robinson,et al.  The human placenta methylome , 2013, Proceedings of the National Academy of Sciences.

[29]  Heng Li,et al.  Tabix: fast retrieval of sequence features from generic TAB-delimited files , 2011, Bioinform..

[30]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[31]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[32]  M. Esteller,et al.  Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient , 2012, Epigenetics.

[33]  Paul Flicek,et al.  Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers , 2015, Genome research.

[34]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[36]  Nuria Lopez-Bigas,et al.  Gitools: Analysis and Visualisation of Genomic Data Using Interactive Heat-Maps , 2011, PloS one.

[37]  M. Esteller,et al.  Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.

[38]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[39]  T. Gingeras,et al.  active intergenic regulatory elements De novo DNA demethylation and non-coding transcription define , 2013 .

[40]  David T. W. Jones,et al.  Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. , 2013, Cancer cell.

[41]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[42]  M. Esteller,et al.  Infinium DNA Methylation Microarrays on Formalin-Fixed, Paraffin-Embedded Samples. , 2018, Methods in molecular biology.

[43]  Gary D Bader,et al.  Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.

[44]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[45]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[46]  Haoyang Cai,et al.  CDCOCA: A statistical method to define complexity dependence of co-occuring chromosomal aberrations , 2011, BMC Medical Genomics.

[47]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[48]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[49]  Charles Y. Lin,et al.  Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer , 2016, Genome Biology.

[50]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[51]  E. Raineri,et al.  Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers. , 2015, Genome research.

[52]  Brian J. Stevenson,et al.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. , 2012, Genome research.

[53]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.